First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641

NCT05853835 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
72
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

LAPIX Therapeutics Inc.